Alloy Therapeutics UK Ltd · 11–50 people · Series A
Scientist I – Molecular Biology
- Cambridge
- On-site
- £45,000 – £50,000 pa
- Senior
- Permanent
Design and build large-scale synthetic gene loci and transgenic platforms for antibody discovery, using CRISPR/Cas9, RMCE and site-specific integrases. Hands-on molecular biology including PCR, NGS, plasmid construction and flow-cytometric immunophenotyping, within a small multidisciplinary team working from dry-lab design to wet-lab validation.
CRISPR/Cas9 · Recombinase-Mediated Cassette Exchange · Bxb1 +3